We found significantly more CTLA4-expressing TCD3+ cells in AML compared to healthy donors’ T-cells, with 13 of the 15 patients’ samples presenting with >20% of TCD3+CTLA4+/TCD3+. Here, CTLA4 is linked to acute myeloid leukemia.